We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Insulet (PODD) Crush Estimates at Its Next Earnings Report?
Read MoreHide Full Article
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Insulet Corporation (PODD - Free Report) , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, PODD has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, PODD expected to have a loss of 23 cents per share, while it actually produced loss of 19 cents per share, a beat of 16.7%. Meanwhile, for the most recent quarter, the company looked to deliver loss of 16 cents per share, when it actually saw loss of 8 cents per share instead, representing a 50% positive surprise.
Thanks in part to this history, recent estimates have been moving higher for Insulet. In fact, the Earnings ESP for PODD is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for PODD, as the firm currently has a Zacks Earnings ESP of 12.50%, so another beat could be around the corner.
This is particularly true when you consider that PODD has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that PODD could see another beat at its next report, especially if recent trends are any guide.
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Insulet (PODD) Crush Estimates at Its Next Earnings Report?
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Insulet Corporation (PODD - Free Report) , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, PODD has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, PODD expected to have a loss of 23 cents per share, while it actually produced loss of 19 cents per share, a beat of 16.7%. Meanwhile, for the most recent quarter, the company looked to deliver loss of 16 cents per share, when it actually saw loss of 8 cents per share instead, representing a 50% positive surprise.
INSULET CORP Price and Consensus
INSULET CORP Price and Consensus | INSULET CORP Quote
Thanks in part to this history, recent estimates have been moving higher for Insulet. In fact, the Earnings ESP for PODD is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for PODD, as the firm currently has a Zacks Earnings ESP of 12.50%, so another beat could be around the corner.
This is particularly true when you consider that PODD has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that PODD could see another beat at its next report, especially if recent trends are any guide.
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>